Talphera, Inc. (TLPH)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$0.78
+5.36%
Mkt Cap $18.29M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 23, 2026 | $580.00K | — | — | -$0.07 | -$0.06 | +20.00% | — | — |
| Q4 2025 Nov 12, 2025 | — | $1.00K | — | -$0.07 | -$0.11 | -46.67% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.12 | -$0.10 | +16.67% | — | — |
| Q2 2025 May 13, 2025 | — | $27.00K | — | -$0.17 | -$0.16 | +5.88% | — | — |
| Q1 2025 Mar 31, 2025 | — | — | — | -$0.21 | -$0.07 | +66.67% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.20 | -$0.13 | +35.00% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$0.22 | -$0.15 | +31.82% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | -$0.28 | -$0.16 | +42.86% | — | — |
| Q4 2023 Dec 6, 2023 | — | $281.00K | — | -$0.28 | -$0.08 | +71.43% | — | — |
| Q4 2023 Nov 8, 2023 | $263.00K | $117.00K | -55.51% | -$0.29 | -$0.08 | +72.41% | — | — |
| Q3 2023 Aug 10, 2023 | $75.00K | $253.00K | +237.33% | -$0.53 | -$0.41 | +22.64% | — | — |
| Q1 2023 Mar 31, 2023 | $1.65M | — | — | -$0.79 | -$0.75 | +4.68% | — | — |
| Q4 2022 Dec 31, 2022 | — | $252.00K | — | — | -$1.00 | — | — | — |
| Q3 2022 Sep 30, 2022 | $625.00K | $507.00K | -18.88% | -$1.20 | -$0.91 | +23.75% | — | — |
| Q2 2022 Jun 30, 2022 | $550.00K | $570.00K | +3.64% | -$1.50 | $9.60 | +740.00% | — | — |
| Q1 2022 Mar 31, 2022 | $550.00K | $442.00K | -19.64% | -$1.20 | -$1.19 | +0.73% | — | — |
| Q4 2021 Dec 31, 2021 | — | $2.00K | — | — | -$1.24 | — | — | — |
| Q3 2021 Sep 30, 2021 | — | $1.86M | — | — | -$1.40 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | $443.00K | — | — | -$1.65 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | $511.00K | — | — | -$1.58 | — | — | — |